{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-043615","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.411125+00:00","generated_at":"2026-05-30T05:05:06.920239+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Protagenic Therapeutics closes $1.275M private placement of common stock and warrants","bullets":["Closed private placement on Nov 4, 2024; sold 1,948,295 shares of common stock.","Issued series A warrants (18-month term) and series B warrants (5-year term), each exercisable at $0.64 per share.","Gross proceeds of $1.275M; net proceeds to be used for working capital.","Brookline Capital Markets acted as sole placement agent for the offering.","Warrants exercisable only after stockholder approval date; no proceeds from warrants included in gross proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-043615","json":"https://secwatch.observer/filing/0001493152-24-043615.json","markdown":"https://secwatch.observer/filing/0001493152-24-043615.md","text":"https://secwatch.observer/filing/0001493152-24-043615.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224043615/0001493152-24-043615-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224043615/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:05:06.920239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}